This newborn beastie will squander most of that loot on gobbling XRP from the open market, emerging as “XRPN” on Nasdaq (assuming the gods of regulation approve, which is about as certain as a dragon’s appetite). Investors get a neat, regulated window to XRP’s wild world. Closing? Q1 2026, if shareholders and regs don’t throw a wobbler. 🤑😏
Consider the stock split: a sleight of hand where one share becomes four, eight, or thirty-two, yet the magician’s hat remains neither heavier nor lighter. Imagine an investor clutching 200 shares at $300 each-a modest $60,000 throne. A four-for-one split would crown them with 800 shares, each now worth $75. The crown jewels remain unchanged, yet the crowd gasps at the spectacle.
The company, a colossus straddling the prairies of Illinois with the grace of a sleepless octopus, harvested $59.8 million in revenue during its third quarter-a modest triumph over the $56.4 million of the previous year. Its adjusted net income, that elusive specter haunting ledgers since time immemorial, swelled by six percent to $20.5 million, or $0.65 per share. Analysts, those modern-day augurs reading entrails from Excel spreadsheets, had predicted $0.62-a difference so slight it might have been dismissed as chance, if not for the alchemy of asset quality that followed.
Though Base aspires to the lofty ideal of decentralization, these tribulations have exposed the rather flimsy undergarments of Coinbase’s centralized structure. All leading non-stablecoin tokens on Base have taken a tumble in value, a most unfortunate turn of events, though one might say they have merely tripped on the hem of their own ambition. 🌧️
Ethereum (ETH) seems to have caught its second wind after a prolonged period of market speculation. According to on-chain data, Ethereum’s open interest (OI)-the amount of money tied up in speculative futures contracts-has plummeted. We’re talking a 37% drop, from a peak of $30 billion to a humble $19 billion. But here’s the kicker: while OI is down, ETH price has only fallen about 20% from its $4,000 high. Talk about a healthy correction, right? 🏋️♂️
The shares, once peddled in September at $6.881 apiece with the glee of a child selling lemonade, are now eligible for sale earlier than planned. HSDT’s stock, now languishing near $6.50, has embarked on a three-day freefall that would make a lemming pause for thought. A 60% plunge? Why, that’s just a gentle stroll for a stock that once dared to dream of $25.
Beyond Meat, that hollowed-out relic of plant-based ambition, has been a graveyard shift for investors over five years. Even with today’s frenzied leap, its stock remains down 99% from its former life. Yet here it stands, a ghost resurrected by the clamor of short-sellers’ panic and the unquenchable thirst of meme-stock mercenaries.
In the third quarter, as the leaves turned and the world turned with them, Apella unceremoniously sloughed off 219,555 shares of the Vanguard Total International Bond ETF (BNDX), bringing in a pot of about $10.8 million. This wise move was revealed through a formal scroll-what they call an SEC filing, mind you-unleashing a flurry of whispers among the traders regarding the firm’s maneuvers in these turbulent economic times. Despite this extravagant shedding of shares, Apella retained nearly 1.2 million of BNDX, a curious fellow indeed, but perhaps the decision was born of necessity rather than desire.
Matthew Salisbury, who’s probably more excited about this than he should be, posted the gig on LinkedIn. The role is in London, where Wise’s HQ is located. Because nothing says “global” like being in the same city as your headquarters. 🧠
Let’s parse this carnage: Vanguard Total Bond Market ETF (BND) now constitutes 2.7% of Apella’s reportable assets. Cute. They’re playing chess with Monopoly money while Rome burns. Their “total” holdings? A laughable $120.5 million in BND, nestled between $515 million in DFAC and $194 million in DFSD. This isn’t diversification-it’s a junkie rotating between needles. The fund’s net assets? $374.4 billion of institutional heroin. And the dividend yield? 3.76%. A Band-Aid on a severed artery.
